LGVN
Longeveron LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.92M
P/E Ratio
—
EPS
$-1.14
Beta
-0.32
52W High
$1.80
52W Low
$0.47
50-Day MA
$0.94
200-Day MA
$0.75
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Longeveron LLC
Longeveron Inc., a clinical-stage biotechnology company, is dedicated to developing cell therapies for life-threatening and aging-related conditions. The company is headquartered in Miami, Florida.
Fundamentals
| Revenue (TTM) | $1.22M |
| Gross Profit (TTM) | 792,000 |
| EBITDA | $-21.82M |
| Operating Margin | -1200.00% |
| Return on Equity | -135.20% |
| Return on Assets | -68.00% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $0.52 |
| Price-to-Book | 1.64 |
| Price-to-Sales (TTM) | 21.31 |
| EV/Revenue | 9.27 |
| EV/EBITDA | -49.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 4.50% |
| Shares Outstanding | $30.15M |
| Float | $26.53M |
| % Insiders | 9.72% |
| % Institutions | 9.77% |
Analyst Ratings
Consensus ($7.15 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026